KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $278,000 | +39.7% | 81,773 | +54.3% | 0.00% | – |
| Q2 2018 | $199,000 | -7.9% | 52,992 | +0.2% | 0.00% | – |
| Q1 2018 | $216,000 | -11.8% | 52,895 | +0.3% | 0.00% | – |
| Q4 2017 | $245,000 | +28.9% | 52,720 | +97.3% | 0.00% | – |
| Q3 2017 | $190,000 | -31.7% | 26,720 | -30.6% | 0.00% | – |
| Q2 2017 | $278,000 | +1.8% | 38,520 | -12.9% | 0.00% | – |
| Q1 2017 | $273,000 | +5.4% | 44,246 | 0.0% | 0.00% | – |
| Q4 2016 | $259,000 | -14.2% | 44,246 | -22.3% | 0.00% | – |
| Q3 2016 | $302,000 | +27.4% | 56,946 | +58.9% | 0.00% | – |
| Q2 2016 | $237,000 | +41.1% | 35,846 | -0.2% | 0.00% | – |
| Q1 2016 | $168,000 | +80.6% | 35,900 | +94.1% | 0.00% | – |
| Q4 2015 | $93,000 | -11.4% | 18,500 | -37.9% | 0.00% | – |
| Q3 2015 | $105,000 | -64.6% | 29,800 | 0.0% | 0.00% | – |
| Q2 2015 | $297,000 | -1.7% | 29,800 | +25.7% | 0.00% | – |
| Q1 2015 | $302,000 | -14.0% | 23,700 | -4.4% | 0.00% | – |
| Q4 2014 | $351,000 | -10.2% | 24,780 | -12.7% | 0.00% | – |
| Q3 2014 | $391,000 | -10.5% | 28,400 | 0.0% | 0.00% | – |
| Q2 2014 | $437,000 | -9.7% | 28,400 | 0.0% | 0.00% | – |
| Q1 2014 | $484,000 | -34.2% | 28,400 | -50.0% | 0.00% | – |
| Q4 2013 | $736,000 | +70.4% | 56,800 | +32.7% | 0.00% | – |
| Q3 2013 | $432,000 | +58.8% | 42,800 | +17.6% | 0.00% | – |
| Q2 2013 | $272,000 | – | 36,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |